spacer
home > epc > spring 2019 > future-proofing the supply chain
PUBLICATIONS
European Pharmaceutical Contractor

Future-Proofing the Supply Chain

With the regulatory landscape between countries continuing to change and the uncertainty surrounding the changes that Brexit will bring to clinical trial regulations across Europe, it is becoming increasingly important to prepare for changes that might hit the clinical trial supply chain.

With the recent expansion of the clinical trial industry as a result of growing drug innovation and targeted therapies, efforts to tackle ineffectiveness and safety concerns are high on the agenda. From changing import and export regulations to temperature deviation, many challenges will affect the clinical trial supply chain. Planning for these uncertainties, especially in light of prevalent disruptive technologies, now requires more attention than ever.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Simon Jones is the Vice President of Global Products for PRISYM ID, responsible for managing the end-to-end lifecycle of the company product portfolio. He has 20 years of experience in delivering product strategies and product positioning which address market opportunities effectively. Simon is a subject expert in clinical trials labelling, researching this market and discussing industry challenges with PRISYM ID customers and keeping them up-to-date on market trends, regulatory changes, and technology alternatives.
spacer
Simon Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge CPhI & P-MEC China a direct result of surging manufacturing

Shanghai, 22 July, 2019:CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow. The three-day Shanghai event featured 3,200+ exhibiting companies, spanning the entire pharma supply chain, and provides a strong indication of the market’s overall growth patterns and future development.
More info >>

White Papers

Unmet Medical Needs? Impacted by unmet Life Sciences Staffing Needs?

Clinical Professionals

Whilst the majority of Clinical Professionals clients are working to discover and develop innovative, cost effective medicines that address unmet medical needs they are not impacting the unmet needs of training and developing new recruits into the pharma industry. The impact is highlighted within entry level Clinical Trial Administrators and Clinical Research Associates (CTA/CRA). In the past the Pharmaceutical industry had highly developed training programs for these sought after candidates. As the use of outsourcing models and CRO’s has increased and fewer Pharma businesses embark on their own R&D a substantial gap is developing in newly trained Life Science graduates entering the market to commence a career within R&D. As further financial cuts are made within R&D spend this already dire situation continues to escalate.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement